Literature DB >> 30267036

Tenofovir vs Entecavir for Hepatocellular Carcinoma Prevention in Patients With Chronic Hepatitis B: One of These Things Is Not Like the Other.

Jennifer A Flemming1,2, Norah A Terrault3,4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30267036     DOI: 10.1001/jamaoncol.2018.4039

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  5 in total

1.  Tenofovir Treatment Has Lower Risk of Hepatocellular Carcinoma than Entecavir Treatment in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis.

Authors:  Hairong Liu; Yu Shi; John C Hayden; Paul M Ryan; Jamal Rahmani; Guangsheng Yu
Journal:  Liver Cancer       Date:  2020-05-05       Impact factor: 11.740

2.  Tenofovir versus entecavir in lowering the risk of hepatocellular carcinoma development in patients with chronic hepatitis B: a critical systematic review and meta-analysis.

Authors:  Min Li; Tingting Lv; Shanshan Wu; Wei Wei; Xiaohai Wu; Xiaojuan Ou; Hong Ma; Shein-Chung Chow; Yuanyuan Kong; Hong You; Jidong Jia
Journal:  Hepatol Int       Date:  2020-01-03       Impact factor: 6.047

3.  Nucleos(t)ide Analogues for Reducing Hepatocellular Carcinoma in Chronic Hepatitis B Patients: A Systematic Review and Meta-Analysis.

Authors:  Xinhui Wang; Xiaoli Liu; Zhibo Dang; Lihua Yu; Yuyong Jiang; Xianbo Wang; Zhiyun Yan
Journal:  Gut Liver       Date:  2020-03-15       Impact factor: 4.519

Review 4.  Secondary prevention for hepatocellular carcinoma in patients with chronic hepatitis B: are all the nucleos(t)ide analogues the same?

Authors:  Terry Cheuk-Fung Yip; Jimmy Che-To Lai; Grace Lai-Hung Wong
Journal:  J Gastroenterol       Date:  2020-09-24       Impact factor: 7.527

Review 5.  Multiple Roles for Hepatitis B and C Viruses and the Host in the Development of Hepatocellular Carcinoma.

Authors:  Kirk J Wangensteen; Kyong-Mi Chang
Journal:  Hepatology       Date:  2020-11-07       Impact factor: 17.425

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.